Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia-Reference-Cited by-同舟云学术

Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia

Published:2015-05 Issue:5 Volume:45 Page:541-544
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Aitken Samuel L.,Altshuler Jerry,Guervil David J.,Hirsch Elizabeth B.,Ostrosky-Zeichner Luis L.,Ericsson Charles D.,Tam Vincent H.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference15 articles.

1. Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia;American Thoracic Society;Am J Respir Crit Care Med,2005

2. Pharmacodynamics of cefepime in patients with Gram-negative infections;Tam;J Antimicrob Chemother,2002

3. Pharmacokinetics and pharmacodynamics of cefepime in patients with various degrees of renal function;Tam;Antimicrob Agents Chemother,2003

4. Quantitative assessment of combination antimicrobial therapy against multidrug-resistant Acinetobacter baumannii;Lim;Antimicrob Agents Chemother,2008

5. Pharmacokinetics of cefepime: a review;Van der Auwera;J Antimicrob Chemother,1993

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial Intelligence to Close the Gap between Pharmacokinetic/Pharmacodynamic Targets and Clinical Outcomes in Critically Ill Patients: A Narrative Review on Beta Lactams;Antibiotics;2024-09-06

2. Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing;Clinical Microbiology Reviews;2024-06-13

3. Therapeutic drug monitoring of imipenem/cilastatin and meropenem in critically ill adult patients;Journal of Global Antimicrobial Resistance;2024-03

4. Antimicrobial Multidrug Resistance: Clinical Implications for Infection Management in Critically Ill Patients;Microorganisms;2023-10-16

5. Clinical outcomes and safety of intravenous polymyxin B-based treatment in critically ill patients with carbapenem-resistant Acinetobacter baumannii nosocomial pneumonia;International Journal of Antimicrobial Agents;2023-08